BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,227,000 | -2.9% | 8,117 | -6.4% | 0.03% | +8.3% |
| Q2 2022 | $1,264,000 | -54.9% | 8,672 | -63.3% | 0.02% | -44.2% |
| Q1 2022 | $2,803,000 | -18.8% | 23,638 | -5.6% | 0.04% | -12.2% |
| Q4 2021 | $3,452,000 | -0.0% | 25,051 | +0.8% | 0.05% | -7.5% |
| Q3 2021 | $3,453,000 | +48.0% | 24,860 | +3.4% | 0.05% | +55.9% |
| Q2 2021 | $2,333,000 | +56.6% | 24,035 | +10.2% | 0.03% | +47.8% |
| Q1 2021 | $1,490,000 | -14.9% | 21,803 | +6.7% | 0.02% | -20.7% |
| Q4 2020 | $1,751,000 | +91.4% | 20,435 | +45.1% | 0.03% | +70.6% |
| Q3 2020 | $915,000 | +144.7% | 14,081 | +175.2% | 0.02% | +142.9% |
| Q2 2020 | $374,000 | – | 5,117 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |